NCT02903108

Brief Summary

The purpose of the present study was to evaluate the effects of subgingival delivery of boric acid gel as an adjunct to scaling and root planing in chronic periodontitis (CP) patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started May 2015

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 16, 2016

Completed
Last Updated

September 16, 2016

Status Verified

September 1, 2016

Enrollment Period

5 months

First QC Date

September 13, 2016

Last Update Submit

September 15, 2016

Conditions

Outcome Measures

Primary Outcomes (1)

  • Defect depth reduction (%)

    assessed in percentage

    Change from baseline to 6 months

Secondary Outcomes (4)

  • probing depth (mm)

    Change from baseline to 6 months

  • clinical attachment level (mm)

    Change from baseline to 6 months

  • modified sulcus bleeding index

    Change from baseline to 6 months

  • plaque index

    Change from baseline to 6 months

Study Arms (2)

Boric acid group

ACTIVE COMPARATOR

Oral prophylaxis followed by 0.75% boric acid drug in gel form placed in intrabony defects

Drug: SRP plus boric acid gel

Placebo group

PLACEBO COMPARATOR

Oral prophylaxis followed by placebo gel placement in intrabony defects

Drug: SRP plus placebo gel

Interventions

SRP followed by 0.75% boric acid placement into intrabony defect

Boric acid group

SRP followed by placebo gel placement into intrabony defect

Placebo group

Eligibility Criteria

Age25 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Systemically healthy with deep pockets (PD of ≥5mm or CAL ≥4mm) and vertical bone loss ≥3 mm on intraoral periapical radiographs
  • Patients with ≥20 teeth with no history of periodontal therapy in the preceding 6 months nor under any antibiotic therapy

You may not qualify if:

  • Patients on systemic boron therapy
  • Known or suspected allergy to boron supplementation
  • Patients with aggressive periodontitis
  • Tobacco use in any form, smokers, alcoholics
  • Immunocompromised and systemically unhealthy patients
  • Pregnant or lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unknown Facility

Bangalore, Karnataka, 560002, India

Location

MeSH Terms

Conditions

Chronic Periodontitis

Condition Hierarchy (Ancestors)

PeriodontitisPeriodontal DiseasesMouth DiseasesStomatognathic DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Head, Dept of Periodontology

Study Record Dates

First Submitted

September 13, 2016

First Posted

September 16, 2016

Study Start

May 1, 2015

Primary Completion

October 1, 2015

Study Completion

October 1, 2015

Last Updated

September 16, 2016

Record last verified: 2016-09

Locations